<img src="https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7?size=2" nborder="0" align="left" hspace="5" vspace="5" title="22157.jpg" alt="Company Logo"/>Opportunities center on telemedicine-enabled remote trials, hybrid and patient-centric models, e-consent, home support, real-world data, digital sample tracking and Asia-Pacific expansion<div style="float:right;padding:0 0 15px 20px;margin:15px 0 20px 20px;width:300px">
 Decentralized Clinical Trial Technology Platform Market
 <figure>
 <img src="https://ml.globenewswire.com/Resource/Download/2d7183b8-06dd-4411-8ccd-3fd58e37ceb3" title="Decentralized Clinical Trial Technology Platform Market" alt="Decentralized Clinical Trial Technology Platform Market" />
 <figcaption>Decentralized Clinical Trial Technology Platform Market</figcaption>
 </figure>
</div>Dublin, Sept. 03, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- The <a href="https://www.researchandmarkets.com/reports/6264524/decentralized-clinical-trial-technology-platform?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=9t97zs&amp;utm_campaign=2344686+-+Decentralized+Clinical+Trial+Technology+Platform+Market+to+Reach+%246.12+Billion+by+2030+as+Virtual+Research+Adoption+Accelerates&amp;utm_exec=jocamsai" rel="nofollow" target="_blank" title="Decentralized Clinical Trial Technology Platform Market Global Report 2026">"Decentralized Clinical Trial Technology Platform Market Global Report 2026"</a> has been added to ResearchAndMarkets.com's offering. The global decentralized clinical trial technology platform market is experiencing rapid growth as pharmaceutical companies, biotechnology firms, contract research organizations, and healthcare providers expand their use of remote and digitally enabled clinical research models. The market is projected to increase from $2.9 billion in 2025 to $3.37 billion in 2026, representing a compound annual growth rate (CAGR) of 16.5%. <img alt="" height="400" src="//www.researchandmarkets.com/content-images/2529/2529984/1/decentralized-clinical-trial-technology-platform.png" width="600" /> Historical market growth has been supported by the rising adoption of remote clinical research, increasing demand for more efficient patient recruitment, and the growing prevalence of chronic diseases requiring extensive clinical studies. The expansion of telemedicine infrastructure and regulatory support for digital clinical trial methodologies have also encouraged sponsors and research organizations to implement decentralized clinical trial technology platforms. The decentralized clinical trial technology platform market is forecast to reach $6.12 billion by 2030, expanding at a CAGR of 16% between 2026 and 2030. Key growth drivers include advances in virtual trial ecosystems, greater investment in decentralized healthcare technologies, rising demand for real-world evidence, and broader access to clinical research through remote participation. The increasing adoption of personalized clinical trial strategies is also expected to support market expansion. Prominent decentralized clinical trial technology trends include the growing use of patient-centric research models designed to improve participant engagement and retention. Electronic consent, digital enrollment, and automated onboarding workflows are becoming increasingly important for accelerating trial initiation. Demand is also rising for hybrid clinical trials that combine remote participation with traditional research site visits. Direct-to-patient drug delivery, home healthcare support, and regulatory-compliant remote data collection are expected to gain further momentum. These capabilities help clinical trial sponsors reduce participant burden while maintaining oversight of patient safety, protocol compliance, and study performance. Real-time monitoring and integrated digital workflows can also improve data quality across geographically distributed research programs. The increasing adoption of telemedicine is a major driver of the decentralized clinical trial technology platform market. Demand for convenient and accessible healthcare services has encouraged patients and providers to use virtual consultations and remote care systems more frequently. Decentralized trial platforms build on this infrastructure by supporting virtual clinical visits, remote patient monitoring, and real-time digital data collection without requiring participants to make frequent visits to physical research sites. Telehealth utilization data highlights the continued shift toward remote care delivery. According to FAIR Health Inc., national telehealth utilization increased by 7.3% between December 2022 and January 2023, rising from 5.5% to 5.9% of medical claim lines. Broader use of telemedicine is creating a stronger digital foundation for decentralized clinical research and enabling sponsors to reach more diverse patient populations. Market participants are developing digital sample capture platforms and other advanced clinical trial technologies to increase operational efficiency, reduce protocol deviations, strengthen data integrity, and provide real-time visibility across distributed research sites. These solutions can replace fragmented, paper-based processes with connected digital workflows for recording, tracking, transporting, and analyzing clinical trial samples. In March 2026, LabConnect launched SampleGISTICS 2.0, a next-generation application designed to digitize clinical trial sample capture and streamline specimen management at research sites. The platform allows site personnel to scan, record, and transmit participant sample information in real time. It reduces paper requisitions and manual data entry while improving courier coordination, shipment tracking, and oversight across global clinical studies. Insights from previously processed clinical trial samples are also used to optimize workflows and strengthen tracking accuracy. Strategic acquisitions are further shaping the competitive environment. In January 2023, Huma Therapeutics Limited acquired Alcedis GmbH for an undisclosed amount. The transaction combined Huma's digital health platform with Alcedis' clinical research operations capabilities. The acquisition was intended to strengthen end-to-end digital clinical trial delivery and support more efficient, decentralized, and data-driven studies throughout the drug development lifecycle. North America was the largest region in the decentralized clinical trial technology platform market in 2025, supported by advanced digital health infrastructure, substantial clinical research activity, and strong adoption of remote trial technologies. Asia-Pacific is expected to be the fastest-growing region during the forecast period. Regions covered by the market analysis include Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the UK, the USA, Canada, Italy, and Spain. Markets Covered: 1) By Component: Software; Services; Hardware 2) By Delivery Mode: Cloud Based Platforms; Web Based Platforms; On Premise Platforms 3) By Therapeutic Area: Oncology; Neurology; Cardiovascular; Rare Disease; Metabolic Disease 4) By Phase: Phase One; Phase Two; Phase Three; Phase Four; Post Market 5) By End User: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Hospitals And Clinics Subsegments: 1) By Software: Electronic Data Capture Software; Remote Patient Monitoring Software; Clinical Trial Management Software; Telehealth And Virtual Visit Software; Data Analytics And Reporting Software 2) By Services: Platform Implementation And Integration Services; Clinical Trial Design And Consulting Services; Patient Recruitment And Engagement Services; Data Management And Biostatistics Services; Regulatory And Compliance Services 3) By Hardware: Wearable Patient Monitoring Devices; Remote Diagnostic Devices; Mobile Health Devices; Edge Computing Devices; Connectivity And Gateway Devices Time Series: Five years historic and ten years forecast. Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita. Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments. Key Attributes: <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Report Attribute</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">Details</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">No. of Pages</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">250</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Forecast Period</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">2026-2030</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Estimated Market Value (USD) in 2026</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">$3.37 Billion</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Forecasted Market Value (USD) by 2030</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">$6.12 Billion</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Compound Annual Growth Rate</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">16%</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Regions Covered</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">Global</td></tr></table> Companies Featured <ul><li>Oracle Corporation</li><li>IQVIA Holdings Inc.</li><li>Veeva Systems Inc.</li><li>ICON Public Limited Company</li><li>Syneos Health Inc.</li><li>Fortrea Holdings Inc.</li><li>Medable Inc.</li><li>Reify Health Inc.</li><li>Florence Healthcare Inc.</li><li>Castor EDC B.V.</li><li>OpenClinica LLC</li><li>Medrio Inc.</li><li>THREAD Research</li><li>ObvioHealth USA Inc.</li><li>Datacubed Health Inc.</li><li>Curebase</li><li>CluePoints</li><li>uMotif Limited</li><li>SignalPath / Veradigm</li><li>Lindus Health Limited</li><li>Viedoc Technologies</li><li>Cloudbyz Inc.</li><li>Delve Health Inc.</li><li>Bioforum The Data Masters Ltd.</li></ul> For more information about this report visit <a href="https://www.researchandmarkets.com/reports/6264524/decentralized-clinical-trial-technology-platform?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=9t97zs&amp;utm_campaign=2344686+-+Decentralized+Clinical+Trial+Technology+Platform+Market+to+Reach+%246.12+Billion+by+2030+as+Virtual+Research+Adoption+Accelerates&amp;utm_exec=jocamsai" rel="nofollow" target="_blank" title="">https://www.researchandmarkets.com/r/ke3avw</a> About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. 
 Attachment

<ul id="gnw_attachments_section-items">
 <li>
 <a target="_blank" href="https://ml.globenewswire.com/Resource/Download/2d7183b8-06dd-4411-8ccd-3fd58e37ceb3" title="Decentralized Clinical Trial Technology Platform Market" rel="nofollow">Decentralized Clinical Trial Technology Platform Market</a>
 </li>
 </ul>
<pre>CONTACT: 
CONTACT: ResearchAndMarkets.com 
 Laura Wood,Senior Press Manager 
 press@researchandmarkets.com
 For E.S.T Office Hours Call 1-917-300-0470 
 For U.S./ CAN Toll Free Call 1-800-526-8630 
 For GMT Office Hours Call +353-1-416-8900 

</pre> <img alt="" src='https://ml.globenewswire.com/media/NmEzNWIwMGYtZGYwMS00NWUzLWFlZWUtZjg1NzdiYjMyZTc3LTEwMjY3MzctMjAyNi0wOS0wMy1lbg==/tiny/Research-and-Markets.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Decentralized Clinical Trial Technology Platform Market to Reach $6.12 Billion by 2030 as Virtual Research Adoption Accelerates

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn